A carregar...

Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause

OBJECTIVE: Sleep disturbances are common among women in midlife; prevalence increases among perimenopausal/postmenopausal women with vasomotor symptoms. Paroxetine 7.5 mg is the only nonhormonal treatment that has been approved in the United States for moderate to severe vasomotor symptoms associate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Menopause
Main Authors: Pinkerton, JoAnn V., Joffe, Hadine, Kazempour, Kazem, Mekonnen, Hana, Bhaskar, Sailaja, Lippman, Joel
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott-Raven Publishers 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4274337/
https://ncbi.nlm.nih.gov/pubmed/25137243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GME.0000000000000311
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!